Life sciences company picks SUSE Linux Enterprise to virtualize its environment, reduce operating system costs and simplify IT management WALTHAM, Mass., July 1
WALTHAM, Mass., July 1 /PRNewswire-FirstCall/ -- Novell today announced
Invitrogen has selected SUSE(R) Linux Enterprise as the core operating
platform to standardize and virtualize the company's servers. A global
provider of essential life science technologies for research, production and
diagnostics, Invitrogen conducts business in more than 70 countries and offers
35,000 products and services. With the flexibility of SUSE Linux Enterprise
from Novell(R), the company will reduce server licensing costs, virtualize
with support on the VMware platform and simplify migration from Windows and
UNIX servers to Linux*.
"We evaluated several Linux distributions and chose SUSE Linux Enterprise
because it was the most cost-effective and flexible operating system," said
John Merritt, system architect at Invitrogen. "In addition, we look forward
to leveraging the Virtual Machine Interface (VMI)-enabled kernel, which will
give us better performance when running on the VMware virtualization
platform."
SUSE Linux Enterprise will allow Invitrogen to more easily manage its
complex IT environment, consisting of a mix of different platforms and
applications including HP servers, Oracle databases and Web servers, as well
as PeopleSoft ERP applications comprised of e-commerce, human resources,
payroll and customer relationship management. SUSE Linux Enterprise gives the
company the flexibility to run its applications on any platform and better
utilize hardware through cost-effective virtualization.
Invitrogen is also working with PlateSpin, a Novell company that helps
enterprises manage and extend their use of server virtualization in the data
center, for physical-to-physical migration and Linux physical-to-virtual
server migration. The combination of PlateSpin(R) data center management
software and SUSE Linux Enterprise helps companies maximize their IT
investments by leveraging Novell's broad virtualization capabilities.
"SUSE Linux Enterprise can add value to a dynamic organization, such as
Invitrogen, looking to minimize cost and complexity," said Roger Levy, senior
vice president and general manager of Open Platform Solutions at Novell.
"Novell's technology direction, market leadership, continued investment in
Linux, and focus on virtualization make it the industry's most compelling
Linux vendor. We offer a mature and stable Linux distribution, complete with
training and implementation services, enabling our customers to get the most
out of their IT investments."
The next-generation platform for the open enterprise, SUSE Linux
Enterprise is the best-engineered and most interoperable platform for
mission-critical computing, from the desktop to the data center. For more
information on SUSE Linux Enterprise offerings from Novell, visit
http://www.novell.com/linux. For more on how customers around the globe are
leveraging Novell solutions, visit http://www.novell.com/success.
About Novell
Novell, Inc. (Nasdaq: NOVL) delivers the best engineered, most
interoperable Linux* platform and a portfolio of integrated IT management
software that helps customers around the world reduce cost, complexity and
risk. With our infrastructure software and ecosystem of partnerships, Novell
harmoniously integrates mixed IT environments, allowing people and technology
to work as one. For more information, visit http://www.novell.com.
Novell, SUSE and PlateSpin are registered trademarks of Novell, Inc. in
the United States and other countries. *Linux is a registered trademark of
Linus Torvalds. All other third-party trademarks are the property of their
respective owners.
SOURCE Novell, Inc.
